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1. Introduction 
Obstetric practice in developing countries is known for unacceptably high maternal 
morbidity , mortality and perinatal deaths. Factors contributory to these include poor 
health care delivery system, cultural beliefs, poor nutrition, illiteracy, gender inequality, 
teenage pregnancies and high parity. Other factors such as  infections and infestations 
ultimately cause anaemia and increase morbidity and mortality in pregnant women and 
their offspring. Anaemia during pregnancy is a well-known risk for unfavourable 
pregnancy outcomes.  
Globally, anaemia has been found to be the most common complication in pregnancy.  
The World Health Organization (WHO) estimates that more than 40% of non-pregnant and 
over 50% of pregnant women in developing countries are affected. The majority of the cases 
occur in sub-Saharan Africa and South East Asia. In 1993, the World Bank ranked anaemia 
as the 8th leading cause of disease in girls and women in the developing world. Apart from 
maternal morbidity and mortality, neonatal mortality is high among the babies of anaemic 
mothers. 
2. Hematological changes in pregnancy 
Pregnancy is associated with normal physiological changes that assist fetal survival and 
prepares the mother for labour, delivery and breastfeeding. The changes start as early as 4 
weeks of gestation and are largely as a result of progesterone and oestrogen. The total blood 
volume increases steadily from as early as 4 weeks of pregnancy to reach a maximum of 35-
45 % above the non-pregnant level at 28 to 32 weeks.  The plasma volume increases by 40-45 
% (1000mls). Red blood cell mass increases by 30- 33 % (approximately 300mg) as a result of 
the increase in the production of erythropoietin. Erythropoietin levels increase throughout 
pregnancy, reaching approximately 150% of their prepregnancy levels at term.  
The increase is steady until term. The greater increase in plasma volume than the increase in 
red blood cell mass results in a modest reduction in haematocrit, with peak haemodilution 
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occurring at 24-26 weeks. This is termed physiological anaemia of pregnancy (see Fig 1). 
This dilution picture is often normochromic and normocytic. Occasionally physiologic 
anaemia can also be associated with a physiologic macrocytosis, MCV increases to 120fl 
although average at  term  is 104 fl. 
In pregnancy, there is an additional demand of about 1000 mg iron   equivalent  to 60 mg 
elemental iron or 300 mg ferrous sulphate daily.  While the transferrin and total iron binding 
capacity rises, the serum iron falls . Thus women who enter pregnancy in an iron deficient 
state are then unable to meet the demands of pregnancy by diet alone and require 
supplementation. It takes approximately 2-3 weeks after delivery for these haematologic 
changes to revert to pre-pregnancy status. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Graphical representation of haematological changes in pregnancy. 
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3. Epidemiology of anaemia in pregnancy 
Anaemia has been found to be associated with poverty and underdevelopment and  is one 
of the most common  disorders globally. The incidence of anaemia varies from place to place 
even within the same country and depends on the socioeconomic status and level of 
development. The World Health Organization reports anaemia among the top ten most 
important contributors to global ill health and deaths.  It estimated that about a third of the 
world’s population of 7 billion have haemoglobin levels below the WHO criteria for 
diagnosis of anaemia.  The majority of these persons reside in Sub-Saharan Africa and South 
East Asia.  
Pregnant women are particularly considered to be the most vulnerable group because of the 
additional demands that are made on maternal stores during pregnancy.   The average 
global prevalence of anaemia in pregnancy is reported to be 51%.  Like anaemia in the 
general population the prevalence of anaemia in pregnancy varies from 17% in Europe to 52 
% and 60% respectively in Africa and Asia.  In sub-Saharan Africa it is estimated that 20% of 
maternal deaths are associated with anaemia.  It is also a major risk factor for infant iron 
deficiency which has been shown to be associated with adverse behavioural and cognitive 
development of children and low birth weight, which is one of the main risk factors for 
infant mortality.   
4. Definition of anaemia 
The term anaemia refers to the   reduction in the oxygen-carrying capacity of the blood due 
to fewer circulating red blood cells than normal or a reduction in the concentration of 
haemoglobin. The deficiency may occur as a result of a reduction in the production or an 
increased loss of erythrocytes.  
Anaemia is said to occur when the haemoglobin content of blood is below the normal range 
expected for the age and  sex of the individual, provided  that the presence of pregnancy, 
the state of hydration of the individual and the altitude have been taken into account. While 
several authorities and experts accepts the lower limits of normal haemoglobin  
concentration as 12g/dl in women and 14g/dl in men, WHO  accepts up to 11gm percent as 
the normal haemoglobin level in pregnancy.  Thus any haemoglobin level below 11gm in 
pregnancy by WHO standard should be considered as anaemia.  However in most of the 
developing countries the lower limit is often accepted as 10 g/dl because a large percentage 
of pregnant women in this setting with haemoglobin level of 10 g/dl tolerate pregnancy, 
labour and delivery very well and with good outcome.  
The centre for disease control, USA  defined anaemia  as a hemoglobin (Hgb) or hematocrit 
(Hct) value less than the fifth percentile of the distribution of Hgb or Hct in a healthy 
reference population.   
5. Classification of anaemia 
Anaemia can be classified as physiological (eg pregnancy), according to the aetiology (Table 
1)  and red blood cell morphology (Table 2). 
Classification based on red cell morphology classifies anaemia based on the size and shape 
of the red blood cell,(normocytic MCV80-90fl, macrocytic MCV>100fl,  microcytic 
MCV<80fl), as well as .pigmentation (hypochromic, normochromic,  hypochromic) (Table 2).  
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Blood loss 
a. Acute 
i. Antepartum haemorrhage (eg placenta praevia , abruptio 
placenta) 
ii. Intrapartum haemorrhage 
b. Chronic 
i. Hookworm infestation 
ii. Bleeding hemorrhoids 
iii. Peptic Ulcer Disease 
B. Nutritional Anaemia 
i. Iron  deficiency 
ii. Folate deficiency 
iii. B12 deficiency 
C. Bone marrow failure 
a. Aplastic anaemia 
b. Isolated secondary failure of erythropoiesis 
c. Drugs (eg Chloramphenicol, Zidovudine) 
D. Haemolytic  
a. Inherited  
i. Haemoglobinopathies ( eg Sickle cell disorders, 
Thalassemia) 
ii. Red cell Membrane defects ( eg Hereditary spherocytosis, 
elliptocytosis) 
iii. Enzyme deficiencies  (eg G6PD deficiency, Pyruvate kinase 
defeciency) 
b. Acquired 
i. Immune Haemolytic anaemias ( eg autoimmune, 
alloimmune, drug induced) 
ii. Non- Immune Haemolytic anaemias 
a. Acquired membrane defects (eg 
Paroxysmal nocturnal Haemoglobinuria) 
        b.Mechanical damage ( eg Microangiopathic haemolytic anaemia) 
                                iii Secondary to systemic disease (eg renal diseases, liver disease) 
                                iv.Infections (Malaria, Sepsis, HIV) 
             
 
 
 
 
 
 
Table 1. Classification of anaemia based on aetiology. 
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A. Hypochromic Microcytic  
 Iron deficiency  
 Thalassemia 
 Sideroblastic anemia   
 Anaemia of chronic disorders 
 Lead poisoning 
B. Macrocytic 
 Folic acid deficiency  
 Vitamin B12 deficiency  
 Liver disease 
 Myxoedema 
 Chronic Obstructive Pulmonary Disease 
 Myelodysplastic syndromes 
 Blood loss anemia 
C. Normocytic Normochromic  
 Autoimmune haemolytic anaemia 
 Systemic Lupus Erythomatosis 
 Collagen vascular disorders 
 Hereditary spherocytosis 
 Haemoglobinopathies  
 Bone marrow failure 
 Malignancies 
 Myelodysplasia 
 Blood loss anemia 
 Anemia of chronic disease 
 
Table 2. Morphological Classification of Anemia and causes. 
The classifications are not necessarily independent of each other as the cause of the anaemia 
could be multifactorial.  
Anaemia can be classified according to severity as mild, moderate, severe and very severe  
( Table 3). Following the diagnosis and possible cause(s) of anaemia in the pregnant woman, 
management as regards the need for blood transfusions or not will depend on the severity 
as well as rapidity of development of anaemia.  
 
 
 
 Degree of Severity  Haemoglobin level (g/dl) 
Normal haemoglobin level 
Mild  Anaemia  
Moderate 
Severe 
Very severe 
>11g/dl 
9-11g/dl 
7-9g/dl 
4-7g/dl 
<4g/dl 
Table 3. Classification of Anaemia by degree of severity. 
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6. Aetiology 
The causes of anaemia in the general population are generally same for anaemia in 
pregnancy. The causes of anaemia in pregnancy are often multifactorial. In developing 
countries, the major causes of anaemia in pregnancy are nutritional deficiencies, infections 
and infestations, haemorrhage and haemoglobinathies. Anaemia is also seen also in some 
chronic medical disorders like renal and hepatic diseases.  
6.1 Nutrition 
In many regions of the world nutritional deficiency is the major cause of anaemia in 
pregnancy.  The World health Organization ((WHO) estimates that about half of all 
pregnant women globally suffer from nutritional anaemia.  Nutritional anaemia is mainly 
due iron and folate deficiency in diet. Diseases that cause poor dietary intake or 
malabsorption of these nutrients will also result in nutritional anaemia.  
Iron deficiency is the commonest cause of nutritional anaemia in both developing and 
industrialized countries and is usually as a result of poor diet.  Sources of iron include 
meat(liver in particular) vegetables and dairy products. The demand for iron increases in 
pregnancy as it is required by both mother and fetus for growth and development. In 
developing countries the already depleted iron stores as a result of poor diet, too  early, too 
many and too frequent pregnancies are unable to cope with the requirement of 1000mg  of 
iron required during a normal pregnancy. The resultant effect is iron deficiency anaemia. 
Hook worm infestation is another cause of iron deficiency anaemia in the tropics. 
The folic acid requirement is also increased two fold in pregnancy. Normal body stores can 
only last for 3- 4 months. Folate deficiency in pregnancy often develops  as  a result of poor 
dietary intake which is often the case  in developing countries  as well as excess utilization. 
Sources of folate include liver, egg yolk, and leafy green vegetables. Folate deficiency results 
in ineffective erythropoesis. 
Folate deficiency can be further exacerbated in pregnant women with hemoglobinopathies 
as well as in those residing in areas of high malaria endemicity as increased  haemolysis 
leads to high red cell turnover and increased folate demand.  
Vitamin B12 is rare during pregnancy as the daily requirement is as low as 3- 5µg  and liver 
stores last for as long as 2 years. 
6.2 Infections 
Pregnant women are more prone to infections as a result of depressed immunity.  Anaemia 
due to infections is usually as a result of   products from the infecting organisms causing ill 
health, fever, red cell destruction and/ or reduced red cell production. Bacterial infections 
used to be a leading cause of anaemia, however in the tropics and developing countries, 
malaria and more recently, HIV/AIDS are leading contributors to anaemia in pregnancy. 
6.3 Malaria 
Malaria infection is a leading cause of anemia in the tropics both in pregnant and non-
pregnant individuals. Malaria induced anaemia is more profound in pregnancy as the 
susceptibility to malaria is greater in the primigravidae. Anaemia resulting from malarial 
infection is caused by the destruction of infected and uninfected red blood cells as well as 
bone marrow suppression. Red blood cells infected with malaria parasites also accumulate 
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and sequester in the placenta. Macrophages and cytokines(e.g.Tumor necrosis factor ┙, 
Interferon ┛ and interleukin 1),enhance red cell destruction, splenic clearance capacity,and 
depress bone marrow erythropoesis. Concurrent micronutrient deficiencies, infection with  
HIV , hookworm infestation or other chronic inflammatory states  will worsen anaemia in 
these persons. 
6.4 HIV/AIDS 
Anaemia is the most common haematological complication of the Human 
Immunodeficiency Virus (HIV) infection and may be consequent upon the effects of the 
virus itself or treatment with various drugs. The mechanisms of HIV induced anaemia occur 
through three mechanisms of decreased red blood cell production, increased red cell 
destruction and ineffective production of red blood cells. The aetiology of HIV associated 
anaemia is multifactorial and may include the infiltration of the bone marrow by tumour or 
infection, bone marrow suppression  by the virus itself,  the use of  myelosuppressive drugs 
like Zidovudine or drugs that prevent the utilization of folate like cotrimoxazole. Other 
aetiologies include decreased production of erythropoietin , red cell destruction as a result of 
autoantibodies to red blood cells, and nutritional deficiencies.  Nutritional  deficiencies  could 
occur as a result of reduced intake due to difficult in swallowing as a result of oropharnygeal 
thrush, malabsorption or increased catabolism as a result of ill health and associated fever 
from various infections. Apart from iron and folate deficiency, other reported vitamin 
deficiencies in HIV infection include vitamin B12, vitamin B6 and vitamin A. 
6.5 Haemoglobinopathies  
Haemoglobinopathies are inherited disorders affecting haemoglobin structure (Sickle cell 
disorders) or synthesis (thalassemias). They are usually seen in individuals from Africa, the 
Middle East, the Mediterranean, Asia and the Far East. The haemoglobinopathies that cause 
anaemia in pregnancy are sickle cell disorders- HbSS, HbSC and HBS-┚ thalassemia.  
Haemoglobinopathies cause a chronic haemolytic anaemia.  In sickle cell disorders, the 
abnormal haemoglobin S sickles in hypoxic states, predisposing the structurally damaged 
cells to early destruction hence affected persons are chronically anaemic.   Folate demands 
are increased and concurrent infections will worsen anaemia.  
6.6 Haemorrhage 
Acute blood loss as result of ectopic pregnancy, antepartum haemorrhage and abortions are 
common causes of anaemia in pregnancy. Chronic blood loss from worm infestations, 
gastrointestinal ulcers and hemorrhoids results in depletion of iron stores and ineffective 
erythropoesis.  
6.7 Red cell aplasia 
This is a rare cause of anaemia in pregnancy and results from a selective failure of 
erythropoesis. In most cases, the cause is unknown The identified causes of pure red cell 
aplasia include autoimmune diseases (e.g. SLE,)  drugs, and infection with parvovirus B19. 
7. Risk factors for anaemia in pregnancy 
Pregnant women in developing countries of  sub-Saharan Africa, South America and  South 
East Asia are at particular risk of  anaemia in pregnancy as a result of poverty, malnutrition 
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and depleted iron stores from too early, too many and too frequent pregnancies.  
Irrespective of race and economic situation,  the prevalence of anemia in pregnancy is 
highest amongst teenage mothers.  A recent report by Scholl estimates that in a low income 
setting, rates of iron deficiency anemia are 1.8% in the first trimester, 8.2% in the second 
trimester, and 27.4% in the third trimester. 
In all regions of the world, the risk factors for iron deficiency anemia include a diet poor in 
iron-rich foods, a diet poor in iron absorption enhancers, a diet rich in foods that diminish 
iron absorption, gastrointestinal disease affecting absorption, heavy menstrual bleeding and 
postpartum bleeding.  
8. Consequences of anemia in pregnancy 
8.1 Fetal 
The fetal consequences of anaemia in pregnancy are well established and depend not only 
on the severity of anaemia but also on the duration of the anaemic state. A fall in maternal 
haemoglobin below 11.0 g/d1 is associated with a significant rise in perinatal mortality 
rates. The rate of perinatal mortality triples at maternal haemoglobin levels below 8.0 g/d1 
and increase by ten fold when anaemia is very severe. Similar findings have also been noted 
for both infant birth weight and preterm delivery rates. A significant fall in birth weight as a 
result of increase in preterm rate and intrauterine growth restriction has been reported with 
maternal haemoglobin levels  below 8.0 g/d1 . 
8.2 Maternal 
The  presence of, severity and duration of anaemia  affect maternal  as well as fetal well 
being. Women whose means of livelihood involve manual labour may find it difficult to 
earn a living as tolerance and capacity for exercise is reduced.  This is worse if the onset of 
anaemia is acute. When anaemia is of gradual onset  and  is chronic, adequate compensatory 
mechanisms enable the women   to go through pregnancy  and labour without any adverse 
consequences. 
Where anaemia is moderate, there is a substantial reduction in work capacity and she may  
be unable to  cope with household chores and child care.  Women with moderate anaemia 
tend to experience higher rates of morbidity during pregnancy as compared to those with 
mild anaemia. Evidence has shown that a large percentage of maternal deaths due to 
antepartum haemorrhage, pre-eclampsia and infections occur in women with moderate 
anaemia. 
The maternal outcomes in severe anaemia depend on level of decompensation. If not 
recognized early and corrected, the heart is unable to compensate for the severity of 
anaemia and eventual circulatory failure occurs leading to pulmonary oedema and death. 
The women are unable to tolerate third stage of labour and blood losses associated with 
delivery. When the anaemia is very severe, there is a  steep rise in maternal deaths. 
9. Clinical features 
The clinical features of anaemia in pregnant or non pregnant states are dependent on 
rapidity of onset and severity of anaemia. In general, symptoms occur with moderate to 
severe anaemia and are more severe when anaemia has been rapidly progressive. In 
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presence of anaemia the body initiates a number of compensatory mechanisms. The 
symptom (s) that is subsequently felt by the individual is dependent on whether the 
compensation is sufficient or insufficient. As such, a pregnant woman with anaemia may 
be asymptomatic body systems adjust  to reduced haemoglobin mass. Where the patient is 
symptomatic, symptoms may be those of vague ill health, headaches, light headedness, 
tinnitus, intermittent claudication, or symptoms of angina. However, as decomposition 
ensues, there may be palpitations, easy fatigability and patients can present in heart 
failure. 
The signs of anaemia can be general or specific. General signs of anaemia include pallor of 
the mucous membranes, hyperdynamic circulation with tachycardia, a bounding pulse, 
cardiomegaly and a apical systolic flow mummur (haemic mummur) . The specific signs 
are associated with particular types of anaemia e.g  painless glossitis, angular 
stomatitis,ridged or spoon shaped nails, unusual dietary cravings for non-food 
substances(pica) in iron deficiency, jaundice in haemolytic and megaloblastic anaemias,   
neuropathy, widespread melanin pigmentation  in  B12 deficiency.  Hepatoslenomegaly 
(may be difficult to elicit when pregnancy is advanced) may be features of chronic 
hemolytic disorders, megaloblastic anaemia, or other haematologic pathologies. The 
findings of anaemia with fever and spontaneous bruising may be indicative of bone 
marrow failure. 
10. Diagnosis of cause(s) of anaemia 
A detailed history, physical examination and appropriate investigations are necessary for 
the identification of the cause(s) of anaemia. Except in very severe anaemia where there is an 
urgent need to treat the pregnant woman to avoid death, the cardinal rule is to establish the 
cause of anemia before commencing treatment.  
10.1 History  
A detailed history including diet, gynaecological, obstetric,drug  and social history should 
be taken.  As nutritional anaemia is common in developing countries, a detailed enquiry 
into the person’s and diet and feeding habits should  be made. Knowledge of the dietary 
and food habits will be necessary to plan strategies to prevent reoccurrence after 
management of the present anaemic state. It is also important to enquire in detail about 
duration and symptoms of anaemia (if any), symptoms of decompensation and  possible 
predisposing factors. Other specific symptoms  like  a beefy red painful  tongue, discoloured 
nails, parasthesias can also be sought. Previous history of postpartum haemorrhage or 
abortion, drug ingestion should be sought. Ideally, the history should address all possible 
aetiology of anaemia,  features  and its complications. 
10.2 Physical examination 
A good physical examination should confirm the presence of anaemia, possible aetiology 
and signs of decompensation. Where anaemia has been chronic, physical examination may 
reveal cardiomegaly, bounding pulses and a systolic flow murmur (hemic murmur).  In 
acute blood loss the patient can present in shock. On examination the presence of pallor, 
jaundice, spleen and liver size should be documented.   
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10.3 Investigations 
Investigations for anaemia are general and specific. A full blood count is  required as part of 
the general investigation and includes the haemoglobin levels, packed cell volume, white cell 
and platelet counts. Red cell indices include mean  corpuscular  volume (MCV), mean 
corpuscular haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC). 
These indices will in the classify anaemia into either microcytic (MCV <80 fL), macrocytic 
(MCV >100fL) and normocytic (MCV80-100fL) or hypochromic or normochromic (MCH and 
MCHC)., A peripheral blood smear and reticulocyte count are also mandatory.  While 
peripheral blood smear provides information about red cell morphology , variations in size,  
and shape, the reticulocyte count provides information on the marrow response. In the 
presence of anaemia a reticulocyte count less than 2-3 times normal indicates inadequate bone 
marrow response. Elevated neutrophil counts may suggest an infection.and peripheral smears 
that reveal a pancytopenia is suggestive of marrow failure.  Stools should also be examined for 
colour, consistency, occult blood, ova and parasites. It is also important to note that in the 
tropics most of the causes may coexist.  Other specific tests are often dictated by suspected 
cause of the anaemia. In the tropics, it is usual to screen for malaria as it is a well documented 
cause of anaemia in pregnancy. Some specific tests necessary to confirm some common causes 
and features of anemia is shown in Table 4. 
 
1. Iron deficiency 
a. Serum ferritin 
b. Total iron binding 
capacity 
c. Transferrin 
saturation 
d. Marrow iron stain 
2. Haemoglobinopathies 
a. Hb electrophoresis 
3. HIV infection 
a. Detection of antibody to 
HIV using ELISA or 
Western blot assays. 
4. Chronic medical disorders 
a. Liver function tests 
b. Serum electrolyte, 
urea and creatinine  
c. Screening for 
autoimmune diseases 
5. Antepartum haemorrhage 
a. Ultrasonography 
Table 4. Specific  investigations  for some common causes of anaemia. 
11. Treatment 
It is of utmost importance to establish the cause of anaemia prior to definitive management. 
However, features of decompensation, very severe anaemia and acute blood loss require 
immediate red cell transfusion as soon as the required samples have been collected. The 
only caveat is that we must ensure that all necessary samples have been collected before 
transfusion.  
The goal of treatment of anaemia in pregnancy is therefore to maintain wellbeing, identify 
and correct the underlying cause(s) and correct anemia within shortest time possible and 
improve patient quality of life and survival. 
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The definitive management of anaemia depends on the cause. The identified causes must be 
treated appropriately  otherwise the anaemia becomes recurrent.  
By and large, the management of anaemia in a pregnant woman depends on the duration of 
pregnancy, severity of the anaemia and complication (obstetric, medical or both).  
Mild and moderate anaemia in pregnancy as a result of iron deficiency should be carefully 
assessed for the cause and the patient placed on iron therapy apart from the treatment of the 
aetiology. The preferred route of iron replacement is oral route as there is no benefit in 
giving parenteral iron as opposed to oral iron. Ferrous sulphate (200mg per tablet 
containing 67mg elemental iron) is the least expensive and best absorbed form of Iron. 
Ferrous glutamate (300mg per tablet containing 37mg elemental iron) and fumarate can also 
be used where iron sulphate is not tolerated. The optimal doses are 120-200mg daily of 
elemental iron in divided doses. Oral iron should be  given for long enough to correct  the 
anaemia and to replenish iron stores which usually means for at least 6 months. 
Haemoglobin should rise at the rate of approximately 2g/dl every 3 weeks.  Side effects of 
oral iron include gastrointestinal symptoms such as diarrhea, nausea, constipation, 
abdominal pain. 
Parenteral iron may be indicated in cases of poor adherence, intolerable side effects or 
malabsorption of oral iron.  In such situation parenteral iron such as iron dextran or sorbitol 
may be administered by the intravenous or intramuscular route.  The hematological 
response to parenteral iron is not faster than adequate dosage of oral iron but the stores are 
replenished faster. Ferric hydroxide –sucrose (Venofer) is the safest form and is 
administered by slow intravenous injection or infusion usually 200mg in each infusion. Iron 
dextran (Cosmofer) can be given as slow injection or infusion in small doses or as a total 
dose infusion given in one day. 
Total dose Intravenous infusion of iron with iron dextran in pregnancy  (50mg iron per ml) 
Dose (mL) = 0.0442 (Desired Hb - Observed Hb) x Lean Body Weight (45.5 kg + 2.3 kg for 
each inch of patient’s height over 5 feet.) + (0.26 x LBW) + 1g. 
The total dose of iron dextran is added to 500ml normal saline and infused over a period of 
4 hours. The major drawback of parenteral iron is anaphylaxis which can occur within 30 
mins of commencing the infusion and may prove rapidly fatal.  
Intramuscular iron therapy can be given as iron sorbitol (Jectofer)(50mg/ml). Injections 
should be given deep into the gluteal muscle. The drawbacks of intramuscular iron 
include pain and staining of the skin at the injection site,myalgia, athralgia and injection 
abscess 
Severe or very severe anaemia requires the immediate hospitalization of the woman, 
management of heart failure and transfusion of packed cells. Once the emergency is averted, 
the iron replacement is as in mild to moderate anaemia.  
Treatment of anaemia from folate deficiency is with folic acid 5mg daily for 4 months and is 
usually given throughout pregnancy. Vitamin B12 deficiency is rare in pregnancy and is 
treated with intramuscular injections of hydroxocobalamin 1000ug . Initial doses are  6 
injections over 2-3 weeks then 100ug every 3 months. 
Erythropoietin  is beneficial in patients  -with marrow suppression . 100-200U/Kg 3times a 
week until normalization of the red cell and then once a weekly to maintain haemoglobin of 
approximately 12g/dl. 
Treatment of  malaria with artemisin combination therapy,  bacterial infections with 
appropriate antibiotics,  hookworm infestation with mebendazole or Albendazole and use of 
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highly active antiretroviral therapy according to treatment guidelines in HIV infection. 
Other co-morbidities e.g. diabetes, hypertension should also be managed. 
12. Prevention 
Approximately 1g of iron is required during a normal pregnancy. Up to 600mg of iron is 
required for the increase in maternal red cell mass, and a further 300mg for the foetus. These 
requirements exceed the iron storage of most young women and often cannot be met by the 
diet. Therefore, few women avoid depletion of iron reserves by the end of pregnancy. Folate 
requirements are increased approximately twofold in pregnancy (800ug/day vs 400ug/day 
because of transfer of folate to the growing fetus and if diet is insufficient, may exceed the 
body’s stores of folate(5-10mg). 
To prevent anaemia in pregnancy the following are necessary. Routine screening for 
anaemia in adolescence, nutritional education about foods rich in iron(meat, liver, leafy 
green vegetables, legumes) and folate (liver, egg yolk, yeast and leafy green vegetables) to 
encourage consumption, early as well as regular antenatal clinic attendances, iron, folate 
supplementation in pregnancy  and early treatment of concomitant infections.  In areas of 
high malaria endemicity, intermittent prophylactic therapy with pyrimethamine-
sulphodoxine for malaria should also be given at 16-17 weeks and 4 weeks later. A  third 
dose is given in HIV infection. 
13. Conclusion 
Anaemia in pregnancy is a major public health problem in developing countries and is 
associated with an increased risk of maternal and perinatal morbidity and mortality.  
Fortification of foods with iron and folate, routine screening for anaemia from adolescence, 
health education, and prompt treatment of infections and attendance of antenatal facilities 
by pregnant women can reduce this burden. 
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